EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma

Yuewen Sun iD, Ying Zhou, Dan Huang, Zhiguang Zhao, Qingrui Shao, Jianzhe Li, Xiaofang Zhao, Xudong Liu

Journal of Cellular and Molecular Medicine · 2025

DOI: 10.1111/jcmm.70609 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2025. Verfasst von Yuewen Sun und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guangxi University of Chinese Medicine, Nanning, China. Hauptthemen laut MEDLINE: Ferroptosis, Carcinoma, Hepatocellular, Liver Neoplasms, Oxidative Stress. Die Arbeit nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Guangxi Province, Young talents in Gui Pai Xing lin of Guangxi University of Chinese Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Although Erk1/2 has been linked to oxidative stress regulation in hepatocellular carcinoma (HCC), the interplay among Erk1/2, reactive oxygen species (ROS), and iron metabolism remains poorly characterised. The steroidal saponin SSPH I, a recognised ferroptosis inducer, exerts dual pharmacological effects via Erk1/2 and ROS‐dependent pathways. This study aimed to investigate the regulatory mechanisms of Erk1/2 in ferroptosis and oxidative stress and analyse their feedback regulatory effects on Erk1/2 in HCC using SSPH I as a pharmacological probe, and further elucidate the anti‐HCC effects and mechanisms of SSPH I in vitro and in vivo. Mechanistic studies utilised three inhibitors: U0126 (Erk1/2 phosphorylation inhibitor), Ferrostatin‐1 (ferroptosis inhibitor), and N‐acetyl cysteine (ROS scavenger), combined with SSPH I to delineate its effects on cell viability, mitochondrial dynamics, ferroptosis induction and oxidative stress. Mechanistically, SSPH I disrupted mitochondrial function and suppressed HCC cell survival through iron accumulation and ROS generation, while concurrently activating Erk1/2 signalling. Pharmacological inhibition of ROS or iron pathways partially attenuated SSPH I‐induced ferroptosis and ROS generation, but failed to abrogate these effects. Erk1/2 inhibition completely abolished SSPH I‐mediated regulation of the Nrf1/2‐HO‐1 axis and ferroptosis‐related protein expression in cellular and animal models, identifying Erk1/2 as the upstream regulatory node. Notably, while both SSPH I and U0126 monotherapies inhibited xenograft growth, their combined use resulted in antagonistic effects. These findings establish Erk1/2 activation as the central molecular mechanism orchestrating SSPH I‐driven oxidative stress amplification, mitochondrial dysfunction and ferroptosis execution in HCC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

FerroptosisCarcinoma, HepatocellularLiver NeoplasmsOxidative StressMitochondriaMAP Kinase Signaling SystemSaponinsHumansAnimalsReactive Oxygen SpeciesMiceCell Line, TumorMice, NudeIronCell SurvivalXenograft Model Antitumor AssaysButadienesNitriles

Stichwörter der Autor:innen

Erk1/2Nrf1/2ROSSSPH Iferroptosis

Substanzen

Reactive Oxygen SpeciesSaponinsIronU 0126ButadienesNitriles

Autor:innen und Institutionen

  • Guangxi University of Chinese Medicine, Nanning, China.
  • Guangxi Vocational University of Agriculture, Nanning, China.
  • Yunnan Grassroots Medical Industry Development Co. Ltd, Kunming, China.

ORCID-Profile: Yuewen Sun

Förderung

  • National Natural Science Foundation of China
  • Natural Science Foundation of Guangxi Province
  • Young talents in Gui Pai Xing lin of Guangxi University of Chinese Medicine
  • Qihuang Project Team of Guangxi University of Chinese Medicine
  • Natural Science Foundation of Guangxi Zhuang Autonomous Region

Zitieren

APA

Sun, Y., Zhou, Y., Huang, D., Zhao, Z., Shao, Q., Li, J., Zhao, X., & Liu, X. (2025). Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.70609

Vancouver

Sun Y, Zhou Y, Huang D, Zhao Z, Shao Q, Li J, et al. Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma. Journal of Cellular and Molecular Medicine. 2025. doi:10.1111/jcmm.70609

BibTeX
@article{Sun2025,
  author = {Sun, Yuewen and Zhou, Ying and Huang, Dan and Zhao, Zhiguang and Shao, Qingrui and Li, Jianzhe and Zhao, Xiaofang and Liu, Xudong},
  title = {Erk1/2 Orchestrates SSPH I‐Induced Oxidative Stress, Mitochondrial Dysfunction and Ferroptosis in Hepatocellular Carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2025},
  doi = {10.1111/jcmm.70609}
}
Kostenlos starten →